← Back to all trials
Recruiting
NCT07368972
Study of DISC-0974-201 in Participants With IBD and Anemia
Conditions: Inflammatory Bowel Disease (IBD), Anemia, Inflammatory Bowel Disease (IBD); Anemia
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 21
Sponsor: Disc Medicine, Inc
Location: One of a Kind Clinical Research Center, LLC Scottsdale Arizona
Summary
This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
Eligibility Criteria
Inclusion Criteria:
Participants must meet all the following criteria at screening (unless otherwise specified) to be eligible for enrollment in the study:
1. Aged ≥18 years at the time of signing informed consent.
2. Established diagnosis of IBD (CD, UC, or IBD-unclassified) based on documented findings on both endoscopy and histopathology.
3. Baseline endoscopy at screening with modified Mayo Score for UC and CDAI for Crohn's Disease to include mild disease as defined below:
a. CDAI of \
Source: ClinicalTrials.gov (NCT07368972). StuddyBuddy aggregates publicly available trial information.
